- 50+ clinical sites in Poland, Bulgaria
- 50+ investigators in neurology and psychiatry
- Pharmacokinetic trials
- Experience with depot neuroleptics
Schizophrenia
- numerous pharmacokinetic trials in 300 patients, single and multiple dose
Depression
- two phase III trials in 280 patients
Cerebral Stroke
- two phase III trials in 60 patients